Exhibit 16.1
August 17, 2018
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7561
Re: Biocrude Technologies USA, Inc.
Dear Sirs/Madams:
We have read Item 4.01 of the Current Report on Form 8-K dated August 16, 2018 of Biocrude Technologies USA, Inc. and we agree with the statements made therein concerning our firm.
Very truly yours,
/s/ DMCL
DALE MATHESON CARR-HILTON LABONTE LLP
CHARTERED PROFESSIONAL ACCOUNTANTS